Pourquoi les patients choisissent-ils Israël pour la résection de l'intestin grêle ?
Accédez à des solutions avancées de résection de l'intestin grêle dans des cliniques de confiance .
| Israël | Turquie | Espagne | |
| Résection de l'intestin grêle | - | de $12,150 | de $18,000 |
Jour 1 : Arrivée
Jour 2 : Pré-opération
Jour 3 : Procédure de résection de l'intestin grêle
Jours 4 à 10 : Post-opération
Semaine 2 à 6 : Rééducation
Semaine 7-10
Semaine 11+
Veuillez noter qu'il s'agit d'une directive générale et que les temps de récupération individuels peuvent varier. Suivez toujours les conseils de vos professionnels de santé.
Le Professeur Merimsky dirige l'Unité d'Oncologie des Tissus Mous et Osseux au Centre Médical Sourasky, avec plus de 25 ans d'expérience spécialisée dans les chirurgies complexes du cancer.
Le Dr Pelles Sharon est spécialisée dans la résection de l'intestin grêle au centre médical Sourasky (Ichilov), avec une vaste expérience dans les traitements du cancer et la recherche clinique.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.
He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.
Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.